Lonza has released Capsugel Enprotect, a capsule solution for intestinal drug delivery. The ingredient doesn’t disintegrate during stomach transit and releases its contents only in the intestine, the company says. According to the press release release, this solution will simplify the manufacturing process, mitigating the need for additional coating or sealing on the capsule. The delivery solution is designed for small molecules, peptides, proteins, and RNA-based therapeutics. 

www.lonza.com